Weight-loss drugmaker Novo Nordisk’s shares fall on disappointing study

by

Shares in Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, plunged on Friday after it announced disappointing results of a new drug study.

Leave A Comment

Your email address will not be published. Required fields are marked *